This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Pharma Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: David E. Alonzo: Innovator in Pharmaceutical Formulations
Introduction
David E. Alonzo is a notable inventor based in Foster City, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid oral dosage forms. His work focuses on enhancing the efficacy and delivery of hormone-related medications.
Latest Patents
David E. Alonzo holds a patent for "Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists." This patent includes combination solid oral dosage forms containing 40 mg of a specific compound, along with hormone replacement medicaments. The patent also outlines processes for making and using these solid oral dosage forms. He has 1 patent to his name.
Career Highlights
David is currently associated with Sumitomo Pharma Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has the potential to improve treatment options for patients requiring hormone therapies.
Collaborations
Throughout his career, David has collaborated with talented professionals, including Kathleen D. Ullmer and Minli Xie. These collaborations have contributed to the advancement of his research and the development of new pharmaceutical solutions.
Conclusion
David E. Alonzo is a dedicated inventor whose work in pharmaceutical formulations is paving the way for improved medical treatments. His innovative approach and collaboration with other experts highlight his commitment to advancing healthcare solutions.